Low molecular weight heparin and cancer survival: clinical trials and experimental mechanisms

被引：0
|
作者：
Ning Zhang
Weihua Lou
Fang Ji
Lihua Qiu
Benjamin K. Tsang
Wen Di
机构：
[1] Shanghai JiaoTong University,Department of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine
[2] Shanghai Key Laboratory of Gynecologic Oncology,Macau Institute for Applied Research in Medicine and Health3, State Key laboratory of Quality Research in Chinese Medicine
[3] Macau University of Science and Technology,Department of Obstetrics & Gynecology and Cellular & Molecular Medicine, Interdisciplinary School of Health Sciences, University of Ottawa, and Chronic Diseases Program
[4] Ottawa Hospital Research Institute,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2016年 / 142卷
关键词：
Cancer; Low molecular weight heparin; Survival; Randomized trial; Molecular mechanisms;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1807 / 1816
页数：9
相关论文
共 50 条
  • [21] EXPERIMENTAL AND CLINICAL VALIDATION OF THE PROPHYLACTIC ANTITHROMBOTIC EFFECTS OF A LOW-MOLECULAR-WEIGHT HEPARIN (ENOXAPARIN)
    FAREED, J
    WALENGA, JM
    HOPPENSTEADT, D
    BORRIS, LC
    LASSEN, MR
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1991, 17 : 319 - 328
  • [22] Low molecular weight heparin
    Vanpee, D
    Gillet, JB
    Swine, C
    ANNALS OF EMERGENCY MEDICINE, 2000, 36 (03) : 277 - 277
  • [23] The effect of low molecular weight heparin (LMWH) on cancer survival. A systematic review and meta-analysis (MA) of randomized trials.
    Lazo-Langner, Alejandro
    Goss, Glenwood D.
    Spaans, Johanna N.
    Rodger, Marc A.
    BLOOD, 2006, 108 (11) : 215A - 216A
  • [24] The effect of low molecular weight heparin on survival in patients with advanced malignancy
    Klerk, CPW
    Smorenburg, SM
    Otten, HM
    Lensing, AWA
    Prins, MH
    Piovella, F
    Prandoni, P
    Bos, MMEM
    Richel, DJ
    van Tienhoven, G
    Büller, HR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) : 2130 - 2135
  • [25] DETERMINATION OF LOW-MOLECULAR WEIGHT HEPARIN IN CLINICAL LABORATORY
    VANPUTTEN, J
    VANDERUIT, M
    BEUNIS, M
    HEMKER, HC
    HAEMOSTASIS, 1984, 14 (02) : 205 - 210
  • [26] Heparin and low-molecular-weight heparin
    Gray, Elaine
    Mulloy, Barbara
    Barrowcliffel, Trevor W.
    THROMBOSIS AND HAEMOSTASIS, 2008, 99 (05) : 807 - 818
  • [27] Overall survival with warfarin versus low-molecular-weight heparin in cancer-associated thrombosis
    Patell, R.
    Chiasakul, T.
    Redd, R.
    Khan, A. M.
    McCarthy, E. P.
    Neuberg, D.
    Zwicker, J. I.
    THROMBOSIS RESEARCH, 2021, 200 : S72 - S73
  • [28] LOW MOLECULAR WEIGHT HEPARIN (LMWH) RESISTANCE IN CANCER PATIENTS
    Nasser, N. J.
    Na'Amad, M.
    Gabizon, A. A.
    ANNALS OF ONCOLOGY, 2012, 23 : 519 - 520
  • [29] VTE and Cancer: Edoxaban is not inferior to low molecular weight Heparin
    不详
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2018, 45 (03) : 209 - 209
  • [30] The survival benefit of low molecular weight heparin over unfractionated heparin in pediatric trauma patients
    Khurrum, Muhammad
    Asmar, Samer
    Henry, Marion
    Ditillo, Michael
    Chehab, Mohamad
    Tang, Andrew
    Bible, Letitia
    Gries, Lynn
    Joseph, Bellal
    JOURNAL OF PEDIATRIC SURGERY, 2021, 56 (03) : 494 - 499
12345